WATCH: @elmayermd.bsky.social, of @danafarber.bsky.social and @harvardmed.bsky.social, highlights the @fda.gov approval of camizestrant plus a CDK4/6 inhibitor for HR+, HER2–, emergent ESR1-mutated breast cancer. #bcsm #oncology

Read our coverage of the approval: www.onclive.com/view/fda-app...

WATCH 🎥: @elmayermd.bsky.social, of @danafarber.bsky.social and @harvardmed.bsky.social, discusses the @fda.gov approval of camizestrant for emergent ESR1-mutated breast cancer. #bcsm #oncology

Full video ➡️: www.onclive.com/view/dr-maye...

Mirna Jarosz, CEO of #LiquidCellDx, explains how her company's #liquidbiopsy captures information about the #tumormicroenvironment, providing critical treatment guidance.

🎧 Listen now → www.ontargetpodcast.com

#OnTarget #PrecisionMedicine #Oncology #Immunotherapy #CancerDiagnostics #AI

WATCH 🎥: Shimoli Barot, MD, of @clevelandclinic.bsky.social, discusses PATINA data showing improved PFS with palbociclib-based maintenance in HR-positive, HER2-positive metastatic breast cancer. #bcsm #oncology

Full video 👀: www.onclive.com/view/dr-baro...

WATCH 📺: Shimoli Barot, MD, of @clevelandclinic.bsky.social, considers how palbociclib-based maintenance could be sequenced with frontline T-DXd plus pertuzumab in HER2-positive metastatic breast cancer. #bcsm #oncology

Full video ➡️: www.onclive.com/view/dr-baro...

📈 The IDMC overseeing an ongoing phase 2 MRD translational study of IMNN-001 in newly diagnosed advanced ovarian cancer has recommended the trial continue without modification. #gyncsm #oncology

More insights ➡️: www.onclive.com/view/idmc-re...

📰 At the 2026 International Invasive Lobular Carcinoma Symposium, @ucsfcancer.bsky.social clinicians and researchers will share their experiences and insights about future treatment directions. #bcsm #oncology

Read more ➡️: www.onclive.com/view/ucsf-br...

The Mayo Clinic reported promising patient results for minibeam radiotherapy, which splits a standard beam into half-millimeter beamlets, creating high-dose "peaks" and low-dose "valleys" where healthy tissue can recover. shorturl.at/n2l4n #radiotherapy #oncology #tumors #sarcoma #skincancer

This #RareCancerDay, NORD is sharing findings from a survey of oncologists we conducted with @medliveofficial.bsky.social.

What we found: 1 in 2 oncologists don't feel confident recognizing a rare #cancer.

Read our full findings: bit.ly/4cXKhgn

#RareCancer #oncology

Join Takara Bio for this virtual symposium on advancing oncology biomarker research! Explore cell-free RNA, total RNA-seq, and single-cell spatial multiomics with leading experts.

📅 October 7, 2026 | 9:00 AM PT

📍 Register now! buff.ly/Q8MkSIo

#Oncology

💥 The @fda.gov has granted orphan drug designation to SOT106 in STS in addition to a fast track designation in osteosarcoma, giving the ADC dual designations for both sarcoma subtypes.

Full details 📈: www.onclive.com/view/sot106-...

#scmsm #oncology

FDA Flashback: ✨August 2026✨ in #BreastCancer
🔹 sNDA filed for gedatolisib in PIK3CA-mutant HR+/HER2– ABC
🔹 Fast track for PARG inhibitor ETX-19477 in BRCAm disease
🔹 2 giredestrant PDUFA dates ahead #bcsm #oncology

Learn more 🔎: www.onclive.com/view/fda-fla...

Registration is open for the 4th SOHO-Israel Meeting & 10th International Davidoff Conference, Nov 19–20, 2026, in person or online.

Register: hematology2026.forms-wizard.biz
Read more: sohoinsider.com/news/4th-soh...

#SOHO #Hematology #Oncology

Adjuvant avelumab numerically improved RFS vs placebo, without reaching statistical significance, in patients with high-risk stage III Merkel cell carcinoma, according to Shailender Bhatia, MD, of @fredhutch.org. #melsm #oncology

More insights ➡️: www.onclive.com/view/adjuvan...

🎙️ Discover one of our keynotes for the 22nd Annual Meeting of the Cancéropôle Grand Sud-Ouest !

Find all information about the congress: kgso.fr/events/22nd-...

#JGSO #Oncology #CancerResearch

FDA advisers have just started to review Grail's Galleri multi-cancer detection test.

You can tune in here:

#cancer #liquidbiopsy #diagnostics #oncology #MedSky

Telo Genomics reports higher residual-myeloma detection with its experimental blood test. The comparison involved only 42 matched samples, and larger validation studies are needed.

#Biotechnology #Oncology #Health

Disclaimer: This is NOT a financial advice

💗 Join us for HerHealth Oncology CME Conference 2026

⏳ 16 DAYS TO GO!

📅 Oct 9–10, 2026 | 📍 New York City & Virtual

Earn 10 CME, 10 ABIM MOC & 10 Nursing Contact Hours.

👉 Register: www.emedevents.com/herhealth-on...

#HerHealth2026 #Oncology #CME #Nursing#BreastCancer #GynecologicOncology#Cancer

#clinicalstrials #clinicalresearch #lifesciences #lifesciencessector #ClinicalTrialsOntario #InvestOntario #clinicaltrialsregulations #drugdevelopment #newmedicines #clinicaltrialdelivery #oncology #precisionmedicine #rarediseases #AIenabledtrials #CROs #tariffs #Trumptariffs
zurl.co/E0Mxj

👏We are proud to welcome 18 new Editorial Board Members to Cancers (August 2026). Wishing our new EBMs huge success in their research and journal contributions! 🌟
🔗Read more: www.mdpi.com/about/announ...
#CancersMDPI #Oncology #Research #OpenAccess